Skip to main content

Table 2 Adjusted odds ratios for positive MDRO screening

From: Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates

 

Unadjusted OR

(95% CI)

P value

Adjusted OR

(95% CI)

P value

CRE or CRAB

    

Use of tracheostomy or endotracheal tube

30.232 (16.694, 54.747)

< 0.001

20.017 (8.003, 50.065)

< 0.001

Previous antibiotic exposure

19.788 (9.588, 40.838)

< 0.001

3.691 (1.413, 9.640)

0.008

Previous CRE or CRAB carriage history

45.333 (22.330, 92.034)

< 0.001

13.329 (5.597, 31.741)

< 0.001

Admission to the medical department

40.690 (9.834, 168.362)

< 0.001

6.601 (1.366, 31.907)

0.019

Peripheral vascular disease

6.776 (2.914, 15.761)

< 0.001

4.704 (1.433, 15.444)

0.011

Liver disease

6.938 (2.596, 18.544)

< 0.001

3.933 (1.078, 14.358)

0.038

MRSA

    

Previous MRSA carriage history

10.720 (4.422, 25.990)

< 0.001

12.262 (4.982, 30.184)

< 0.001

Liver disease

3.768 (1.301, 10.917)

0.015

4.247 (1.455, 12.395)

0.008

  1. Note: MDRO = multidrug-resistant microorganism, OR = odds ratio, CI = confidence interval, CRE = carbapenem-resistant Enterobacterales, CRAB = carbapenem-resistant Acinetobacter baumannii, MRSA = methicillin-resistant Staphylococcus aureus